Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Artiva Biotherapeutics, Inc.

Clinical trials sponsored by Artiva Biotherapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Immune cell therapy shows promise for tough lupus cases Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Immune cell therapy shows promise for tough lupus cases

Disease control Ongoing

This early-stage study tests a new treatment called AB-101 for people with lupus nephritis or other hard-to-treat lupus. AB-101 uses donated natural killer cells to boost the body's ability to fight the disease. The study aims to see if this approach is safe and can help patients…

Phase 1 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC